• Angiotensin (1-7): Mechanism to Translation

  2026-09-14

  Angiotensin (1-7) is more than a counter-regulatory renin–angiotensin system peptide: it is a mechanistic probe for Mas receptor biology, fibrosis, inflammation, metabolism, neuroprotection, and emerging host–pathogen questions. This article connects pathway insight with practical experimental design and translational decision-making.

• 3-Methyladenine Workflows for Autophagy Research

  2026-09-13

  Use 3-Methyladenine to interrogate class III PI3K-dependent autophagy, nutrient-stress responses, and migration phenotypes with time-aware controls. This guide connects practical 3-MA workflows to emerging cuproptosis research while highlighting interpretation limits and troubleshooting strategies.

• Antibiotic Use and Resistance in Psychiatric Hospitals

  2026-09-12

  This retrospective study links antibacterial-drug utilization with bacterial resistance patterns in a psychiatric hospital during the 2022 epidemic. Its main contribution is the integration of hospital prescribing metrics, microbiological submission data, and susceptibility results to inform stewardship in a high-contact psychiatric-care setting.

• Magneto-Piezoelectric Scaffolds Target JAK2-STAT3

  2026-09-11

  This ACS Nano study develops a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic reprogramming of Icam1+ macrophages. Its central contribution is linking JAK2-STAT3 activation and MAPK-JNK suppression to oxidative phosphorylation, pro-reparative immune activity, and improved regeneration of infectious bone defects.

• Z-VDVAD-FMK: Apoptosis Pathway Mapping

  2026-09-11

  Z-VDVAD-FMK helps researchers distinguish caspase-2-linked mitochondrial apoptosis from downstream caspase-3/7 activity and caspase-independent death. This workflow also shows how to use it as a mechanistic control when studying HOXC8-associated pyroptosis in lung cancer models.

• Bedaquiline: An Energy-Centered Assay Framework

  2026-09-10

  Bedaquiline is a diarylquinoline antibiotic whose energy-targeting mechanism supports a rigorous framework for tuberculosis and cancer-metabolism research. This article distinguishes direct bacterial ATP-synthase inhibition from host-directed GSK3 biology and translates both into practical assay decisions.

• Haloprogin: Evidence from a Foundational Antifungal Study

  2026-09-10

  The 1970 study by Harrison and colleagues established Haloprogin as a topical antifungal with dermatophyte activity comparable to tolnaftate, while also demonstrating activity against Candida species and selected Gram-positive bacteria. Its combination of serial-dilution testing, fungicidal endpoints, and steroid-maintained guinea pig infection models provides a useful framework for interpreting spectrum, formulation, and translational limitations.

• Morin: A Mechanism-First Neuroinflammation Probe

  2026-09-09

  Morin is a natural flavonoid antioxidant with applications spanning oxidative-stress biology, mitochondrial metabolism, and fluorescent aluminum detection. This article presents a phenotype-first framework for using Morin in neurological and metabolic disease assays without confusing preclinical mechanism with clinical treatment.

• LG 101506 (RXR modulator) in Cell Assays

  2026-09-09

  A scenario-based guide to using LG 101506 (RXR modulator), SKU B7414, in cell viability, proliferation, and cytotoxicity workflows. It covers formulation controls, protocol design, interpretation, and evidence boundaries for RXR signaling pathway research.

• LY2603618: A Biomarker-Led Chk1 Assay Strategy

  2026-09-08

  LY2603618 is a selective Chk1 inhibitor for investigating replication stress, checkpoint dependence, and chemotherapy sensitization. This article develops a biomarker-led assay framework based on PPP2R2A biology, helping researchers distinguish genuine Chk1 dependency from nonspecific DNA damage.

• miR-3180 Rewires Lipid Metabolism in HCC

  2026-09-08

  Hong et al. show that miR-3180 suppresses hepatocellular carcinoma by simultaneously limiting SCD1-dependent fatty acid synthesis and CD36-mediated lipid uptake. The study combines patient-tissue analysis, mechanistic reporter assays, functional cancer-cell experiments, lipid measurements, and xenograft validation to connect one microRNA with two complementary metabolic inputs.

• Dacarbazine: Mechanism, Evidence, and Workflow

  2026-09-07

  Dacarbazine is an antineoplastic chemotherapy drug that produces DNA damage after metabolic activation. Its research value depends on separating growth inhibition from cell killing in controlled viability assays.

• Gepotidacin for Uncomplicated Urogenital Gonorrhea

  2026-09-07

  This phase 2 randomized study evaluated whether a single oral dose of gepotidacin could eradicate uncomplicated urogenital Neisseria gonorrhoeae infection. Both tested doses produced at least 95% microbiological eradication in the evaluable population, while failures shared a higher observed MIC and a common gene mutation, highlighting both the promise and resistance-monitoring needs of this novel mechanism.

• Ibrexafungerp Activity Against Resistant Candida auris

  2026-09-05

  Wiederhold and colleagues evaluated ibrexafungerp against fluconazole-resistant Candida auris using broth microdilution and a delayed-treatment neutropenic mouse model. The study found consistent in vitro activity and meaningful in vivo efficacy, supporting glucan synthase inhibition as a strategy for difficult-to-treat invasive candidiasis while highlighting the limits of extrapolating animal results to clinical care.

• CUDC-907: Practical PI3K/HDAC Workflow

  2026-09-04

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of pathway signaling, acetylation, cell-cycle distribution, and apoptosis in cancer cell models. This guide translates the supplied product dossier into an executable workflow and defines handling, QC, and interpretation limits; the compound is not intended for diagnostic, therapeutic, or clinical use.

8106 records 2/541 page Previous Next 12345 下5页 Last page